Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era - real-world data from Hungary
Autologous stem cell transplantation (ASCT) is the standard treatment of primary refractory or relapsed Hodgkin-lymphoma, which can provide a cure rate of about 50%. The aim of our study was to analyze the data of 126 HL patients undergoing AHSCT in Hungary between 01/01/2016 and 31/12/2020. We asse...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2023
|
| Sorozat: | ANNALS OF HEMATOLOGY
102 No. 9 |
| Tárgyszavak: | |
| doi: | 10.1007/s00277-023-05354-8 |
| mtmt: | 34067943 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/28123 |